Global Subdural Hematoma Treatment Market, By Type (Acute Subdural Hematoma, Subacute Subdural Hematoma, Chronic Subdural Hematoma), Treatment (Anticonvulsants, Diuretics, Corticosteroids, Surgery, Catheter, Physical Therapy, Speech Therapy, Vitamin K Therapy, Others), Diagnosis (CT scan, MRI, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Symptoms (Seizures, Change in behavior, Headache, Nausea, Confusion, Dizziness, Vomiting, Lethargy, Apathy, Weakness, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Subdural Hematoma Treatment Market
Subdural hematoma treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.70% in the above mentioned forecast period.
Subdural hematoma is a neurological disease which is characterised by the accumulation of blood between the dura mater (brain covering) and the brain's surface. It is a type of traumatic brain injury and caused due to serious head injuries. Signs and symptoms of this disorder include seizures, change in behavior, headache, nausea, confusion, dizziness, vomiting, lethargy, apathy, weakness and others. It is also known as intracranial hematoma or subdural hemorrhage.
Rise in the prevalence of subdural hematoma, growing number of head injuries, and alcohol abuse are the major factors that will influence the market growth rate. Also, increase in the incidence of haemophiliacs, rising geriatric population, growing usage of blood thinners and rising initiatives by government and private organisations to spread awareness about the disease are the factors that will expand the subdural hematoma treatment market.
Rise in the research and development activities and emerging new markets will provide beneficial opportunities for the subdural hematoma treatment market in the forecast period of 2021-2028.
However, high cost of treatment and complications associated with the disease such as brain herniation, seizures and repeated bleeding are the factors that will hinder the market growth. Lack of awareness about the preventive measures and available treatment will further challenge the subdural hematoma treatment market in the forecast period mentioned above.
This subdural hematoma treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the subdural hematoma treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Subdural Hematoma Treatment Market Scope and Market Size
The subdural hematoma treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the subdural hematoma treatment market is segmented into acute subdural hematoma, subacute subdural hematoma and chronic subdural hematoma.
- On the basis of treatment, the subdural hematoma treatment market is segmented into anticonvulsants, diuretics, corticosteroids, surgery, catheter, physical therapy, speech therapy, vitamin K therapy and others.
- On the basis of diagnosis, the subdural hematoma treatment market is segmented into CT scan, MRI and others.
- On the basis of dosage, the subdural hematoma treatment market is segmented into tablet, injection and others.
- On the basis of route of administration, the subdural hematoma treatment market is segmented into oral, intravenous and others.
- On the basis of symptoms, the subdural hematoma treatment market is segmented into seizures, change in behavior, headache, nausea, confusion, dizziness, vomiting, lethargy, apathy, weakness and others.
- On the basis of end-users, the subdural hematoma treatment market is segmented into clinic, hospital and others.
The subdural hematoma treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Subdural Hematoma Treatment Market Country Level Analysis
The subdural hematoma treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel.
The countries covered in the subdural hematoma treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the subdural hematoma treatment market due to the presence of major key players, growing investment for R&D activities, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Subdural hematoma treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Subdural Hematoma Treatment Market Share Analysis
Subdural hematoma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global subdural hematoma treatment market research.
The major players covered in the subdural hematoma treatment market report are Novartis AG, Sanofi, Pfizer Inc., Johnson & Johnson Private Limited, Abbott, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Sunovion Pharmaceuticals Inc., GW Pharmaceuticals plc., AstraZeneca, GlaxoSmithKline plc, H. Lundbeck A/S, Takeda Pharmaceutical Company Limited., Sumitomo Dainippon Pharma Co., Ltd., Biocon, Merck KGaA, Cadila Pharmaceuticals, Eisai Co., Ltd., Cipla Inc., Glenmark Pharmaceuticals Limited, Mankind Pharma, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., and Sun Pharmaceutical Industries Ltd., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-